Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010

Cited by (517)

Items 201–300 of 517

1. Large simple trials: really, it can't be that simple!
   Robert M. Califf · 2014 · European Heart Journal
2. Randomized controlled trials in pediatric patients had higher completion rates than adult trials: a cross-sectional study
   Edouard Dufetelle, Geert W. ‘t Jong, Florentia Kaguelidou · 2018 · Journal of Clinical Epidemiology
3. A Decade On: Systematic Review of ClinicalTrials.gov Infectious Disease Trials, 2007–2017
   Ian S. Jaffe, Karen Chiswell, Ephraim L. Tsalik · 2019 · Open Forum Infectious Diseases
4. Target and actual sample sizes for studies from two trial registries from 1999 to 2020: an observational study
   Adrian Gerard Barnett, Paul Glasziou · 2021 · BMJ Open
5. Transparencia en la investigación clínica: registro de los ensayos clínicos y publicación de resultados
   Clara Pérez‐Mañá, Carola Llonch, Magı́ Farré · 2012 · Medicina Clínica
6. Critical analysis of contemporary clinical research in muscle‐invasive and metastatic urothelial cancer
   Matthew D. Galsky, Ryan Hendricks, Robert Scott Svatek, Rick Bangs, Jean H. Hoffman-Censits, Jessica Mary Clement, Robert Dreicer, Elizabeth Ann Guancial, Noah M. Hahn, Seth P. Lerner et al. · 2013 · Cancer
7. The Current Landscape of Oral Squamous Cell Carcinoma: A Comprehensive Analysis from ClinicalTrials.gov
   Zhaolei Zou, Бин Ли, Shuqiong Wen, Dongjia Lin, Qian‐Nan Hu, Zhi Wang, Juan Fang · 2022 · Cancer Control
8. Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov
   Kristjan Ukegjini, Marisa Guidi, Kuno Lehmann, Krisztian Süveg, Paul Martin Putora, Nikola Čihorić, Thomas Steffen · 2023 · Cancers
9. Cautionary tales in the interpretation of observational studies of effects of clinical interventions
   Ian A Scott, John Attia · 2016 · Internal Medicine Journal
10. De la investigación no clínica a los ensayos y registros clínicos: retos y oportunidades en la investigación biomédica
    J. M. de la Torre Hernández, Elazer R. Edelman · 2017 · Revista Española de Cardiología
11. Using ClinicalTrials.gov to Understand the State of Clinical Research in Pulmonary, Critical Care, and Sleep Medicine
    Jamie L. Todd, Kyle R. White, Karen Chiswell, Asba Tasneem, Scott M. Palmer · 2013 · Annals of the American Thoracic Society
12. Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database
    Kevin D. Hill, Heather Henderson, Christoph Paul Vincent Hornik, Jennifer S. Li · 2015 · Cardiology in the Young
13. Automatic Curation of Clinical Trials Data in LinkedCT
    Oktie Hassanzadeh, Renée J. Miller · 2015 · Lecture notes in computer science
14. Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short?
    Karen Barnard, Wanda C. Lakey, Bryan C. Batch, Karen Chiswell, Asba Tasneem, Jennifer B. Green · 2016 · PLoS ONE
15. Learning disease relationships from clinical drug trials
    Bryan Haslam, Luis Perez-Breva · 2016 · Journal of the American Medical Informatics Association
16. Current efforts in research of pleural mesothelioma—An analysis of the ClinicalTrials.gov registry
    Krisztian Süveg, Paul Martin Putora, Thierry Berghmans, Markus Glatzer, Veljko Kovac, Nikola Čihorić · 2018 · Lung Cancer
17. Mining patterns of adverse events using aggregated clinical trial results.
    Jake Luo, Guo‐Qiang Zhang, Rong Xu · 2013 · Europe PMC (PubMed Central)
18. Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities
    Anil Babu Payedimarri, Samir Mouhssine, Saleh Aljadeeah, Gianluca Gaïdano, Raffaella Ravinetto · 2023 · BMJ Oncology
19. Studies of Artificial Intelligence/Machine Learning Registered on ClinicalTrials.gov: Cross-Sectional Study With Temporal Trends, 2010-2023
    Shoko Maru, Michael D Matthias, Ryohei Kuwatsuru, Ross J. Simpson · 2024 · Journal of Medical Internet Research
20. A method for probing disease relatedness using common clinical eligibility criteria.
    Mary Regina Boland, Riccardo Miotto, Chunhua Weng · 2013 · PubMed
21. Challenges in economic modeling of anticancer therapies: an example of modeling the survival benefit of olaparib maintenance therapy for patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer
    Robert Hettle, John William Posnett, John Borrill · 2015 · Journal of Medical Economics
22. A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy
    Bismarck C.L. Odei, Dustin L. Boothe, Sameer R. Keole, Carlos Vargas, Robert L. Foote, Steven E. Schild, Jonathan B. Ashman · 2016 · International Journal of Particle Therapy
23. Oncology from an HTA and Health Economic Perspective
    Clément François, Junwen Zhou, Michał Pochopień, Leila Achour, Mondher Toumi · 2018 · Recent results in cancer research/Recent Results in Cancer Research
24. Accelerated Growth of Cellular Therapy Trials in Musculoskeletal Disorders: An Analysis of the NIH Clinical Trials Data Bank
    Nicolas Santiago Piuzzi, Mitchell K. Ng, Morad Chughtai, Anton Khlopas, Prem N. Ramkumar, Steven F. Harwin, Michael A. Mont, Thomas W. Bauer, George F. Muschler · 2019 · Orthopedics
25. Registered Interventional Clinical Trials for Old Populations With Infectious Diseases on ClinicalTrials.gov: A Cross-Sectional Study
    Lingmin Chen, Menghua Wang, Yi Yang, Jing Shen, Yonggang Zhang · 2020 · Frontiers in Pharmacology
26. The landscape of investigator‐initiated oncology trials conducted in mainland China during the past decade (2010–2019)
    Ye Cao, Lin‐Miao Ye, Zhong Fan, Wei Yang, Liying Chen, Yun Mei, De‐Ying He, Wen‐Jin Mo · 2023 · Cancer Innovation
27. Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981–2012
    Karin U. Travers, Rachel H. Sallum, Meghan D. Burns, Charles E. Barr, Mary Stanley Beattie, Chris Leo Pashos, Bryan R. Luce · 2014 · Pharmacoepidemiology and Drug Safety
28. An Analysis of Registered Clinical Trials in Otolaryngology from 2007 to 2010: ClinicalTrials.gov
    David L. Witsell, Kristine A. Schulz, Walter Tsong Lee, Karen Chiswell · 2013 · Otolaryngology
29. Regulatory Approval and Biotechnology Product Disclosures*†
    Luminiţa Enache, Lynn Li, Edward J. Riedl · 2022 · Contemporary Accounting Research
30. Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.
    Cahan, Amos, Anand, Vibha · 2017 · PLOS ONE
31. Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas
    Jacquelyne Lam, Sarah J. Lord, Kylie E Hunter, Robert John Simes, Thuyen Vu, Lisa Maree Askie · 2015 · The Medical Journal of Australia
32. Analysis of Suspension of Clinical Trials for Drug Registration in China
    Xian Wei Su, Xiaocong Pang, Xin Zeng, Yi Qin Gao, Yimin Cui, Haixue Wang · 2021 · Frontiers in Pharmacology
33. Current Characteristics of Herbal Medicine Interventions for Cancer on Clinical Databases: A Cross-Sectional Study
    Bo-Young Youn, Ji‐Hyun Kim, Yong-Kyu Jo, Sang-Hoon Yoon, Ji-Yeong Im, Hyo‐Jung Kim, Jae-Dong Lee, Seong‐Gyu Ko · 2023 · Integrative Cancer Therapies
34. Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries
    Tatsuya Ito · 2016 · PLoS ONE
35. Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy
    Nicholas J. Giacalone, Nastaran Milani, Bhupendra Rawal, Paul J. Catalano, Paul Linh Nguyen, Jonathan Daniel Schoenfeld, Roy B. Tishler, Danielle Nina Margalit · 2018 · International Journal of Radiation Oncology*Biology*Physics
36. Twenty‐two years’ experience registering trials in a low‐middle income country: The Peruvian Clinical Trial Registry
    Christoper Alexander Alarcon-Ruiz, Joel Sack Roque‐Roque, Paula Heredia, Angie Roxana Gómez‐Briceño, Antonio M. Quispe · 2019 · Journal of Evidence-Based Medicine
37. Too hot to handle: Mood states moderate implicit approach vs. avoidance tendencies toward food cues in patients with obesity and active binge eating disorder
    Johannes Krehbiel, Georg Halbeisen, Simone Kühn, Yeşim Erim, Georgios Paslakis · 2021 · Journal of Psychiatric Research
38. A New Look at an Old Therapy
    Robert M. Califf · 2012 · JAMA
39. Women and girls’ participation in haemophilia clinical trials
    Stacey A. Fedewa, Lorraine A. Cafuir, Leonard A. Valentino, Andee Koo, Ana G. Antun, Christine L. Kempton · 2024 · Haemophilia
40. Applications for Oncologic Drugs: A Descriptive Analysis of the Oncologic Drugs Advisory Committee Reviews
    John K. Chan, Tuyen K. Kiet, Bradley J. Monk, Nichole Young‐Lin, Kevin Blansit, Daniel Stuart Kapp, Idoroenyi Usua Amanam · 2014 · The Oncologist
41. Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023
    Zachary Schonrock, Sierra Brackeen, Kikka E. Delarose, Tiffany Q.‐D. Tran, Lauren R. Cirrincione · 2024 · British Journal of Clinical Pharmacology
42. Acceso público a los resultados de los ensayos clínicos con medicamentos: ¿es esto suficiente para clínicos y pacientes?
    Rafael Dal‐Ré · 2014 · Medicina Clínica
43. A “Three-Plus-One” Evaluation Model for Clinical Research Management
    David M. Dilts · 2013 · Evaluation & the Health Professions
44. Clinical Trials in Precision Oncology
    Susan M. Mockus, Sara E. Patterson, Cara M. Statz, Carol J. Bult, Gregory J. Tsongalis · 2015 · Clinical Chemistry
45. Emerging Therapies for Congestive Heart Failure
    Thomas Joseph Povsic · 2017 · Clinical Pharmacology & Therapeutics
46. Long-Term Collaboration Network Based on ClinicalTrials.gov Database in the Pharmaceutical Industry
    Heyoung Yang, Hyuck Jai Lee · 2018 · Sustainability
47. Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines
    Xu Liu, Ling‐Long Tang, Yan‐Ping Mao, Qing Liu, Ying Hao Sun, Lei Chen, Jin‐Ching Lin, Jun Ma · 2018 · The Oncologist
48. Pharmacoinformatics approaches in the discovery of drug-like antimicrobials of plant origin
    Duaa Ahmad Khan, Syed Damin Abbas Hamdani, Sahar Iftikhar, Sohaib Zafar Malik, Najam‐us‐Sahar Sadaf Zaidi, Alvina Gul, Mustafeez Mujtaba Babar, Münir Öztürk, Bengü Türkyılmaz Ünal, Tuba Mert Gönenç · 2021 · Journal of Biomolecular Structure and Dynamics
49. Analysis of 473 US Head and Neck Cancer Trials (1996‐2014)
    Anand K. Devaiah, Charles Murchison · 2015 · Otolaryngology
50. So You Want to Be a Principal Investigator
    Mansoor Noorali Saleh, Gurudatta Naik · 2018 · Journal of Oncology Practice
51. Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review
    Muthiah Vaduganathan, Ayman Samman‐Tahhan, Ravi B. Patel, Anita A. Kelkar, Lampros Papadimitriou, Vasiliki V. Georgiopoulou, Stephen John Greene, Andreas P. Kalogeropoulos, Eric David Peterson, Gregg C. Fonarow et al. · 2016 · International Journal of Cardiology
52. Emergence of Large Treatment Effects From Small Trials—Reply
    John P. A. Ioannidis, Tiago Pereira, Ralph I. Horwitz · 2013 · JAMA
53. Advances in polymeric nanoparticles for oral drug delivery: mechanisms, challenges, emerging trends, and preclinical to clinical perspectives
    Mehrukh Zehravi, Sharuk L. Khan, Jeetendra Kumar Gupta, Patibandla Jahnavi, Ramenani Hari Babu, Nithin Vidiyala, Anuradha Averineni, G. Dharmamoorthy, Venkata Lakshamana Sagar Dantinapalli, Selvaraja Elumalai et al. · 2025 · 3 Biotech
54. Assessing Research Results in the Medical Literature
    Robert M. Califf, Jonathan McCall, Robert A. Harrington · 2013 · JAMA Internal Medicine
55. Pragmatic clinical trial design in emergency medicine: Study considerations and design types
    Cameron J. Gettel, Maame Yaa A. B. Yiadom, Steven L. Bernstein, Corita R. Grudzen, Bidisha Nath, Fan Li, Ula Hwang, Erik P. Hess, Edward R. Melnick · 2022 · Academic Emergency Medicine
56. Should comparative effectiveness research ignore industry-funded data?
    Adam G. Dunn, Enrico W Coiera · 2014 · Journal of Comparative Effectiveness Research
57. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
    N. Goswami, E. Tsalik, S. Naggie, W. Miller, J. Horton, Christopher D. Pfeiffer, C. Hicks · 2014 · Trials
58. Public access to clinical trials: Lessons from an organizational implementation of policy
    Grant D. Huang, Jane K. Altemose, Timothy J. O’Leary · 2017 · Contemporary Clinical Trials
59. Bringing data monitoring committee charters into the sunlight
    David L. DeMets, Deborah A. Zarin, Frank W. Rockhold, Susan S. Ellenberg, Thomas R. Fleming, Janet Turk Wittes · 2023 · Clinical Trials
60. Training the Next Generation of Data Monitoring Committee Members
    Thomas R. Fleming, Janet Turk Wittes, Mona Fiuzat, Michael R. Bristow, Frank W. Rockhold, Jason T. Connor, Benjamin R. Saville, Brian Lee Claggett, Isabella Cavagna, William T. Abraham et al. · 2024 · JACC Heart Failure
61. Systematic Reviews and Meta‐Analysis
    Iain Crombie · 2021 · Wiley eBooks
62. Reporting Compliance of Stroke Trials: Cross-Sectional Analysis
    Konark Malhotra, Appaji Rayi, Monica Khunger, Stephanie Thompson, David S. Liebeskind · 2017 · Journal of Stroke and Cerebrovascular Diseases
63. The changing landscape of data monitoring committees—Perspectives from regulators, members, and sponsors
    Amit Bhattacharyya, Paul P. Gallo, Adam Crisp, Lisa Morrissey LaVange, Geert Molenberghs, Frank Pétavy, Jonathan H. Seltzer · 2018 · Biometrical Journal
64. Why Clinical Trials Stop: The Role of Genetics
    Olesya Razuvayevskaya, Irene López, Ian Dunham, David Ochoa · 2023 · medRxiv
65. Measuring What Matters in Trial Operations: Development and Validation of the Clinical Trial Site Performance Measure
    Mattia Bozzetti, Alessio Lo Cascio, Daniele Napolitano, Nicoletta Orgiana, Vincenzina Mora, Stefania Fiorini, Giorgia Petrucci, Francesca Resente, Irène Baroni, Rosario Caruso et al. · 2025 · Journal of Clinical Medicine
66. Update on JAMA 's Policies on Conflicts of Interest, Trial Registration, Embargo, and Data Timeliness, Access, and Analysis
    Howard Bauchner, Phil Fontanarosa · 2012 · JAMA
67. Cross-sectional analysis of UK research studies in 2015: results from a scoping project with the UK Health Research Authority
    Tim Clark, Richard Wicentowski, Matthew Robert Sydes · 2018 · BMJ Open
68. Generating evidence for therapeutic effects: the need for well-conducted randomized trials
    Robert M. Califf, Lesley H. Curtis, Robert A. Harrington, Adrian F. Hernandez, Eric David Peterson · 2020 · Journal of Clinical Investigation
69. Factors associated with North–South research collaboration focusing on HIV/AIDS: lessons from ClinicalTrials.gov
    Hesborn Wao, Yan Wang, Melvin A. Wao, Juliana A. Were · 2021 · AIDS Research and Therapy
70. An Argument for Fewer Clinical Trials
    Kirstin Borgerson · 2016 · The Hastings Center Report
71. Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database
    Nikola Čihorić, Eugenia Vlaskou Badra, Alexandros Tsikkinis, Vikas Prasad, Stephanie G. C. Kroeze, Ivan Igrutinovic, Branislav M. Jeremic, Marcus Beck, Sebastian Zschaeck, Peter Wust et al. · 2018 · Radiation Oncology
72. Registration of phase 3 crossover trials on ClinicalTrials.gov
    Lijuan Zeng, Riaz Qureshı, Shilpa Viswanathan, Lea T. Drye, Tianjing Li · 2020 · Trials
73. Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types
    Daniel Buergy, Julian Riedel, Gustavo Renato Sarria, Michael Ehmann, Davide Scafa, Maurizio Grilli, Frederik K. Wenz, Ralf‐Dieter Hofheinz · 2020 · International Journal of Cancer
74. The Current Landscape of Clinical Studies Focusing on Thyroid Cancer: A Comprehensive Analysis of Study Characteristics and Their Publication Status
    Yihao Liu, Бин Ли, Qiuyi Zheng, Jia Hui Xu, Jie Li, Fenghua Lai, Bo Lin, Sui Peng, Weiming Lv, Haipeng Xiao · 2020 · Frontiers in Endocrinology
75. Patient-Centered Clinical Trials Decision Support using Linked Open Data
    Bonnie MacKellar, Christina Schweikert, Soon Ae Chun · 2014 · International Journal of Software Science and Computational Intelligence
76. Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov
    Vinay K. Prasad, Jeffery A. Goldstein · 2015 · European Journal of Cancer
77. Studies of pain management in osteoarthritis: bedside to policy
    Elena Losina, Elizabeth E. Dervan, Meghan E. Daigle, Jeffrey Neil Katz · 2013 · Osteoarthritis and Cartilage
78. Deriving and Critiquing an Empirically Based Framework for Pharmaceutical Ethics
    Wendy L. Lipworth, Miles Little · 2013 · AJOB Empirical Bioethics
79. Cost-efficiency of knowledge creation
    Rafael Struck, Georg Baumgarten, Mária Wittmann · 2014 · Current Opinion in Anaesthesiology
80. Spatial and temporal structure of the clinical research based on mesenchymal stromal cells: A network analysis
    Paul Monsarrat, Philippe Kémoun, Jean‐Noël Vergnes, Luc Sensebé, Louis Casteilla, Valérie Planat‐Benard · 2016 · Cytotherapy
81. Pediatric Antibacterial and Antifungal Trials From 2007 to 2017
    Joshua T. Thaden, Karen Chiswell, Ian S. Jaffe, Stephen P. Bergin, William E. Yang, Andrew Romaine, Jamie N. Roberts, Sumathi Nambiar, John J Farley, Daniel K. Benjamin et al. · 2018 · PEDIATRICS
82. The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
    Yi Que, Wei Xiao, BS Xu, XZ Wen, Desheng Weng, Xing Zhang · 2018 · BMC Cancer
83. Global clinical trial mobilization for COVID-19: higher, faster, stronger
    Reed F. Beall, Aidan Hollis · 2020 · Drug Discovery Today
84. The Clinical Trials Transformation Initiative: Looking back, looking forward
    John Hunter Alexander, Jacqueline Corrigan‐Curay, Mark McClellan · 2018 · Clinical Trials
85. Global patterns of hemophilia drug trials, hemophilia care, and health care measures
    Stacey A. Fedewa, Leonard A. Valentino, Andee Koo, Lorraine A. Cafuir, Theresa Wicklin Gillespie, Tyler W. Buckner, Duc Quang Tran, Ana G. Antun, Christine L. Kempton · 2025 · Research and Practice in Thrombosis and Haemostasis
86. Systematic data ingratiation of clinical trial recruitment locations for geographic-based query and visualization
    Jake Luo, Weiheng Chen, Min Wu, Chunhua Weng · 2017 · International Journal of Medical Informatics
87. The Characteristics of Clinical Studies Submitted to the Saudi Food and Drug Authority from 2009 until 2020
    Mohammad H. Aljawadi, Renad A. Aldhahri, Mansour S. AlMetwazi, Azher Mustafa Arafah, Abdullah T Khoja · 2021 · Saudi Pharmaceutical Journal
88. Research evaluating the effectiveness of dementia interventions in low‐ and middle‐income countries: A systematic mapping of 340 randomised controlled trials
    Maximilian Salcher‐Konrad, Shi Cheng, Disha Patel, David McDaid, Claudia Iveth Astudillo‐García, Kirsten Bobrow, Jacky Chak Pui Choy, Adelina Comas‐Herrera, Andra Fry, Martin Richard John Knapp et al. · 2023 · International Journal of Geriatric Psychiatry
89. Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period
    Huageng Huang, Yuyi Yao, Xinyi Deng, Huawei Weng, Zegeng Chen, Le Yu, Zhao Wang, Xiaojie Fang, Huangming Hong, He Huang et al. · 2023 · Frontiers in Immunology
90. Timing, modifications, and tenor of firms' mandatory R&D disclosures: The role of competition
    Chandrika Rathee, Sumeet Malik, Rossella Salandra · 2024 · Research Policy
91. Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov
    Chris R. Stockmann, Catherine M.T. Sherwin, Krow Ampofo, Adam L. Hersh, Andrew T. Pavia, Carrie L. Byington, Robert M. Ward, Michael G. Spigarelli · 2013 · International Journal of Antimicrobial Agents
92. Entry Into New Therapeutic Areas: The Effect of Alliance on Clinical Trials
    Kinya Okada, Shintaro Sengoku · 2018 · Therapeutic Innovation & Regulatory Science
93. Associations between industry involvement and study characteristics at the time of trial registration in biomedical research
    A. Seidler, K. Hunter, N. Chartres, L. Askie · 2019 · PLoS ONE
94. COMPREHENSIVE ANALYSIS OF CLINICAL TRIALS IN PAKISTAN FROM SEPTEMBER 1992 TO FEBRUARY 2019
    Amna Siddique, Amara Zafar, Tooba Irfan · 2022 · Journal of Ayub Medical College Abbottabad
95. Translational research: from basic research to regional biomedical entrepreneurship
    Sang-Min Park, NICHOLAS SPYRIDON VONORTAS · 2022 · Small Business Economics
96. Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)
    Xavier Bonfill, Mónica Ballesteros, Ignasi J. Gich, María Antonia Serrano, Fernando José García López, Gerard Urrútia · 2013 · PLoS ONE
97. How Pharmaceutical Industry Employees Manage Competing Commitments in the Face of Public Criticism
    Wendy L. Lipworth, Kathleen Montgomery, Miles Little · 2013 · Journal of Bioethical Inquiry
98. Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino‐American symposium on clinical and translational medicine
    Jiebai Zhou, Duojiao Wu, Xinqing Liu, Shuoqi Yuan, Xiao-Qiu Yang, Xiangdong Wang · 2012 · Clinical and Translational Medicine
99. Clinical research in Finland in 2002 and 2007: quantity and type
    Elina Hemminki, Jorma Ilmari Virtanen, Piret Veerus, Elena Regushevskaya · 2013 · Health Research Policy and Systems
100. Analysis of Recruitment Strategies: Enrolling Veterans With PTSD Into a Clinical Trial
     Erika M. Roberge, David M. Benedek, Christine E. Marx, Ann M. Rasmusson, Ariel J. Lang · 2017 · Military Psychology